Zobrazeno 1 - 10
of 32
pro vyhledávání: '"S.S. Bernvil"'
Autor:
S.S. Bernvil
Publikováno v:
Transfusion Science. 15:149-154
Therapeutic plasma exchange (PE) has been established as an important adjunct in the treatment of some autoimmune diseases. Behcet's disease has the features of autoimmune disease and multiple reports on the use of PE in small groups of patients have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5becb35fbce92132fc26776fea98d41
https://doi.org/10.1016/0955-3886(94)90089-2
https://doi.org/10.1016/0955-3886(94)90089-2
Publikováno v:
Transfusion Science. 18:45-47
After screening over 100,000 blood donations for the presence of antiHTLV-I antibodies, a final prevalence of 0.0038% was established in a multinational donor population. Among 38,201 donations by Saudi Arabian donors, the prevalence was found to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5b1ef0ce85d5d3b366a9a88d41ceb87
https://doi.org/10.1016/s0955-3886(96)00075-6
https://doi.org/10.1016/s0955-3886(96)00075-6
Publikováno v:
Transfusion Science. 16:257-259
The possible use of marrow progenitor cells derived from peripheral blood was hypothesized almost 30 years ago 1 and confirmed two decades later with the first efforts to collect and preserve human stem cells from peripheral blood during remission af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9813e42774d7af436b13ce26b4c6cf0
https://doi.org/10.1016/0955-3886(95)00018-s
https://doi.org/10.1016/0955-3886(95)00018-s
Publikováno v:
Transfusion science. 18(1)
Blood donor screening for anti-hepatitis B core antigen (anti-HBc) was introduced as a surrogate marker of non-A, non-B hepatitis prior to the availability of a specific test for hepatitis C. In areas endemic for hepatitis B virus (HBV), such as Saud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76f84a009e21aa8f210dbcfd83cb0ea
https://pubmed.ncbi.nlm.nih.gov/10174292
https://pubmed.ncbi.nlm.nih.gov/10174292
Publikováno v:
Vox Sanguinis. 67:405-405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce4b4a6ad8e97962b16fec2aa700afc
https://doi.org/10.1159/000462648
https://doi.org/10.1159/000462648
Autor:
Peter Baumann, Utako Okamoto, L. Stigendahl, Junichiro Yamamoto, Thomas Jürgensen, Roberto Quintavalla, M. Jeran, Zoltán Boda, S. Bjoern, M. Paolicelli, Duncan P. Thomas, Ulla Hedner, R. Ádány, Kálmán Rák, Peter H. Domer, Y. Okada, C. Manotti, György Pfliegler, A. Tóth, László Muszbek, Y. Nagamatsu, H.C. Hemker, Z. Papp, S. Béguin, A.G. Dettori, Y. Tsuda, Hau C. Kwaan, M. Pini, Jolan Harsfalvi, Trevor W. Barrowcliffe, István Tornai, Ma Xi, S.S. Bernvil, Claus-Ch. Heuck, L. Tengborn
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 19:I-VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::011074a2592df399acd29dcf264142dd
https://doi.org/10.1159/000216033
https://doi.org/10.1159/000216033
Publikováno v:
Haemostasis. 19(6)
FVIIa purified from human plasma and spontaneously activated during the purification procedure was given to 4 patients with hemophilia A and inhibitors against FVIIl:C in association with joint bleeds. A dose of 9–20 μg/kg b.w. (700–1,000 U/kg b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae2673e6e84e83abd5d14e9dab31c80
https://pubmed.ncbi.nlm.nih.gov/2516004
https://pubmed.ncbi.nlm.nih.gov/2516004
Autor:
K. Wallevik, Bjarne Kuno Møller, S.S. Bernvil, S.E.H. Jacobsen, E. Zachariae, J.V. Povlsen, B. Laursen
Publikováno v:
Thrombosis research. 53(1)
The presence of VIII:C inhibitors in hemophilic patients causes major problems in the management of bleedings (1). So far, the most promising treatment of high responder patients seems to be daily infusion of high doses of F VIII in order to induce a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::529e273469a0ba25106c07d3f12e898f
https://pubmed.ncbi.nlm.nih.gov/2466347
https://pubmed.ncbi.nlm.nih.gov/2466347
Autor:
M. Paolicelli, Y. Okada, C. Manotti, A. Tóth, Y. Nagamatsu, Zoltán Boda, Ma Xi, R. Ádány, Hau C. Kwaan, Ulla Hedner, Peter Baumann, György Pfliegler, István Tornai, S.S. Bernvil, A.G. Dettori, Z. Papp, Trevor W. Barrowcliffe, Y. Tsuda, L. Stigendahl, M. Pini, Junichiro Yamamoto, László Muszbek, L. Tengborn, H.C. Hemker, Claus-Ch. Heuck, Kálmán Rák, S. Bjoern, S. Béguin, Utako Okamoto, M. Jeran, Thomas Jürgensen, Roberto Quintavalla, Jolan Harsfalvi, Duncan P. Thomas, Peter H. Domer
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 19:361-362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2794fd2f6fad58d214905e14e266ef7d
https://doi.org/10.1159/000216086
https://doi.org/10.1159/000216086
Autor:
Kálmán Rák, S. Béguin, Duncan P. Thomas, A. Tóth, Peter H. Domer, Y. Nagamatsu, Utako Okamoto, László Muszbek, H.C. Hemker, L. Stigendahl, Peter Baumann, Junichiro Yamamoto, S. Bjoern, Claus-Ch. Heuck, Y. Tsuda, Ma Xi, Roberto Quintavalla, Trevor W. Barrowcliffe, L. Tengborn, Ulla Hedner, M. Pini, István Tornai, S.S. Bernvil, Y. Okada, Thomas Jürgensen, Zoltán Boda, Hau C. Kwaan, Z. Papp, Jolan Harsfalvi, György Pfliegler, R. Ádány, A.G. Dettori, M. Paolicelli, M. Jeran, C. Manotti
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 19:358-358
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21e8db18f67811390f58d6b3d02a0687
https://doi.org/10.1159/000216084
https://doi.org/10.1159/000216084